Factor V Leiden can increase the risk of recurrent blood clots, as individuals with the mutation are more susceptible to clot formation. Recurrent clots can lead to complications and long-term health issues. Proper management and preventive measures, including prescribed medication, are crucial to reducing the risk of recurrent clotting events.